A phase 1 study of interleukin-15 in combination with avelumab in relapsed or refractory T-cell lymphoma

Simple item page
dc.contributor.authorGordon, Max J.
dc.contributor.authorDubois, Sigrid
dc.contributor.authorBryant, Bonita
dc.contributor.authorNg, Samuel
dc.contributor.authorConlon, Kevin
dc.contributor.authorMiljković, Miloš
dc.contributor.authorWaldmann, Thomas
dc.contributor.authorRoschewski, Mark
dc.date.accessioned2026-03-05T19:36:03Z
dc.date.issued2024-06-06
dc.description.urihttps://www.tandfonline.com/doi/full/10.1080/10428194.2024.2326847
dc.format.extent5 pages
dc.genrejournal articles
dc.identifierdoi:10.13016/m2i6zi-7vzv
dc.identifier.citationGordon, Max J., Sigrid Dubois, Bonita Bryant, et al. “A Phase 1 Study of Interleukin-15 in Combination with Avelumab in Relapsed or Refractory T-Cell Lymphoma.” Leukemia & Lymphoma 65, no. 7 (2024): 1008–11. https://doi.org/10.1080/10428194.2024.2326847.
dc.identifier.urihttps://doi.org/10.1080/10428194.2024.2326847
dc.identifier.urihttp://hdl.handle.net/11603/42074
dc.language.isoen
dc.publisherTaylor and Francis
dc.relation.isAvailableAtThe University of Maryland, Baltimore County (UMBC)
dc.relation.ispartofUMBC Biological Sciences Department
dc.relation.ispartofUMBC Faculty Collection
dc.rightsThis work was written as part of one of the author's official duties as an Employee of the United States Government and is therefore a work of the United States Government. In accordance with 17 U.S.C. 105, no copyright protection is available for such works under U.S. Law.
dc.rightsPublic Domain
dc.rights.urihttps://creativecommons.org/publicdomain/mark/1.0/
dc.titleA phase 1 study of interleukin-15 in combination with avelumab in relapsed or refractory T-cell lymphoma
dc.typeText
dcterms.creatorhttps://orcid.org/0000-0001-5848-6320

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
EBSCOFullText02_27_2026.pdf
Size:
612.87 KB
Format:
Adobe Portable Document Format
Download

Collections

UMBC Biological Sciences Department
UMBC Faculty Collection